Home / Pneumococcus, Purified Polysaccharides Antigen / Norway
NO ATC J07AL01 · updated 2 Nov 2026
Pneumococcus, Purified Polysaccharides Antigen shortage in Norway
Is there a Pneumococcus, Purified Polysaccharides Antigen shortage in Norway?
Yes. As of 2 Nov 2026, 1 Pneumococcus, Purified Polysaccharides Antigen product is reported short in Norway, the first since 1 Feb 2026. The company estimate for the return is 31 Dec 2026. Main reason: commercial decision or withdrawal.
Also short in Italy. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Pneumovax injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 0,5 ml ferdigfylt sprøyte av glass | Merck Sharp & Dohme B.V. | 1 Feb 2026 | 31 Dec 2026 | Commercial decision or withdrawal Planlagt utfasing/avregistrering |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).